NIH (National Institutes of Health) stem cell registry underway
This article was originally published in Clinica
Executive Summary
The US National Institutes of Health (NIH) last week began its new website registry of all of the embryonic stem cells eligible for use in federally funded research. It includes 72 stem cell lines - a dozen more than the agency originally estimated would fit the funding criteria President Bush announced on August 9.
You may also be interested in...
US FDA Gene Therapy Accelerated Approval Guidance Will Describe ‘Buckets’ Of Use Scenarios
Forthcoming guidance is expected to describe areas of “low-hanging fruit” and those that are more challenging for use of the expedited pathway, Center for Biologics Evaluation and Research Director Peter Marks said.
FTC Early Findings In PBM Investigation Coming By Mid-Summer, Chair Kahn Says
The agency is also poised to announce another development in its scrutiny of the drug patents listed in the FDA’s Orange Book.
ImmunityBio Will Aim Anktiva At Large Share Of Bladder Cancer Market
Execs Richard Adcock and Patrick Soon-Shiong told Scrip the company sees an addressable US population of about 20,000 and is aiming for ease of physician adoption.